Moreover, 9‐ING‐41 mitigated the adverse effects of ApoE4 on the progression from T2DM to AD through multiple mechanisms and underscores the pivotal role of GSK‐3β in this process. This evidence concerns the gene APOE and type 2 diabetes mellitus.